WuXi PharmaTech Schedules Fourth-Quarter and Full-Year 2013 Earnings Release - WSET.com - ABC13

WuXi PharmaTech Schedules Fourth-Quarter and Full-Year 2013 Earnings Release

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE WuXi PharmaTech (Cayman) Inc.

SHANGHAI, Feb. 10, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quarter and full year of 2013 after the New York Stock Exchange closes on Wednesday, March 5, 2014 (which will be Thursday morning, March 6, 2014 Shanghai time). The earnings release will be available on the investor relations section of the Company's website at http://www.wuxiapptec.com .

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Thursday, March 6, 2014, to discuss the fourth-quarter and full-year 2013 financial results and recent business activities. The conference call may be accessed by calling:

Mainland China    

4001 200 539

Hong Kong         

800 905 927

Singapore           

800 616 3222

United Kingdom

0800 015 9725

United States     

1855 298 3404

United States-New York (toll)   

+1 631 5142 526

Other countries (toll)      

+65 6823 2299

Conference ID   

1551765

A telephone replay will be available two hours after the call's completion at:

Mainland China    

4001 842 240

Hong Kong        

800 966 697

Singapore           

800 616 2127

United Kingdom

0800 169 7301

United States     

1866 846 0868

Conference ID   

1551765

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

For more information, please contact:

Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com
Web: http://www.wuxiapptec.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WSET. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.